Acute renal failure in Ebola viral disease: does new immunomodulation concept by statin acceptable for management?

Viroj WiwanitkitHainan Medical University, Haikou, China, ;Faculty of Medicine, University of Niš, Niš, Serbia, ;Joseph Ayo Babalola University, Ikeji-Arakeji, Nigeria, ;Dr DY Patil Medical University, Pune, India, ;Surin Rajabhat University, Surin, ThailandCorrespondenceViroj Wiwanitkit [email protected]

References

Wiwanitkit V. Ebola virus infection: What should be known? N Am J Med Sci. 2014;6:549–552.
PubMedGoogle Scholar
Baskerville A, Fisher-Hoch SP, Neild GH, Dowsett AB. Ultrastructural pathology of experimental Ebola haemorrhagic fever virus infection. J Pathol. 1985;147:199–209.
PubMed Web of Science ®Google Scholar
Faubel S, Franch H, Vijayan A, et al. Preparing for renal replacement therapy in patients with the Ebola virus disease. Blood Purif. 2014;38:276–285.
PubMed Web of Science ®Google Scholar
Fedson DS, Rordam OM. Treating Ebola patients: A ‘bottom up’ approach using generic statins and angiotensin receptor blockers. Int J Infect Dis. 2015;36:80–84.
PubMed Web of Science ®Google Scholar
Fedson DS, Jacobson JR, Rordam OM, Opal SM. Treating the host response to ebola virus disease with generic statins and angiotensin receptor blockers. MBio. 2015 23;6:e00716.
Google Scholar
Wouters CW, Wever KE, Bronckers I, et al. Short-term statin treatment does not prevent ischemia and reperfusion-induced endothelial dysfunction in humans. J Cardiovasc Pharmacol. 2012;59:22–28.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Acute renal failure in Ebola viral disease: does new immunomodulation concept by statin acceptable for management?

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Acute renal failure in Ebola viral disease: does new immunomodulation concept by statin acceptable for management?

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date